Nathalie Moll, the Director General of the European Federation of Pharmaceutical Industries and Associations, said tariffs on medicines "would create the worst of all worlds". "Tariffs increase costs, disrupt supply chains and prevent patients from getting life-saving treatments," Moll said. Her remark comes after US President Donald Trump announced 100% tariffs on pharma imports.